Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.

Detalles Bibliográficos
Autores: Rosas J; Llinares-Tello F; de la Torre I; Santos-Ramírez C; Senabre-Gallego JM; Valor L; Barber-Vallés X; Hernández-Flórez D; Santos-Soler G; Salas-Heredia E; Carreño L; AIRE-MB Group
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2014
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p7025
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/7025
Nivel de acceso:Acceso abierto
_version_ 1878738992156901376
author Rosas J
author2 Llinares-Tello F
de la Torre I
Santos-Ramírez C
Senabre-Gallego JM
Valor L
Barber-Vallés X
Hernández-Flórez D
Santos-Soler G
Salas-Heredia E
Carreño L
AIRE-MB Group
author2_role author
author
author
author
author
author
author
author
author
author
author
author_browse AIRE-MB Group
Barber-Vallés X
Carreño L
Hernández-Flórez D
Llinares-Tello F
Rosas J
Salas-Heredia E
Santos-Ramírez C
Santos-Soler G
Senabre-Gallego JM
Valor L
de la Torre I
author_facet Rosas J
Llinares-Tello F
de la Torre I
Santos-Ramírez C
Senabre-Gallego JM
Valor L
Barber-Vallés X
Hernández-Flórez D
Santos-Soler G
Salas-Heredia E
Carreño L
AIRE-MB Group
author_role author
collection r-FISABIO. Repositorio Institucional de Producción Científica
description The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.
eu_rights_str_mv openAccess
format article
id ES_b904e5dc17a243f8a4e73894f648f3cf
institution Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:fisabio.fundanetsuite.com:p7025
publishDate 2014
publishDateSort 2014
publisher CLINICAL & EXPER RHEUMATOLOGY
publisherStr CLINICAL & EXPER RHEUMATOLOGY
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
spelling Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice. Rosas J Llinares-Tello F de la Torre I Santos-Ramírez C Senabre-Gallego JM Valor L Barber-Vallés X Hernández-Flórez D Santos-Soler G Salas-Heredia E Carreño L AIRE-MB Group The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice. CLINICAL & EXPER RHEUMATOLOGY https://fisabio.portalinvestigacion.com/publicaciones/7025
spellingShingle Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
Rosas J
status_str publishedVersion
title Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_full Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_fullStr Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_full_unstemmed Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_short Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_sort Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
url https://fisabio.portalinvestigacion.com/publicaciones/7025